3ctq: Difference between revisions

Revision as of 03:35, 17 February 2009

This article has been automatically seeded. Changes to this page should pertain to the PDB entry only and not to the protein or biomolecule in general.

File:3ctq.png

Template:STRUCTURE 3ctq

Structure of MAP kinase p38 in complex with a 1-o-tolyl-1,2,3-triazole-4-carboxamideStructure of MAP kinase p38 in complex with a 1-o-tolyl-1,2,3-triazole-4-carboxamide

Template:ABSTRACT PUBMED 18462940

About this StructureAbout this Structure

3CTQ is a 1 chain structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

ReferenceReference

^{[xtra 1]}

↑ Cogan DA, Aungst R, Breinlinger EC, Fadra T, Goldberg DR, Hao MH, Kroe R, Moss N, Pargellis C, Qian KC, Swinamer AD. Structure-based design and subsequent optimization of 2-tolyl-(1,2,3-triazol-1-yl-4-carboxamide) inhibitors of p38 MAP kinase. Bioorg Med Chem Lett. 2008 Jun 1;18(11):3251-5. Epub 2008 Apr 25. PMID:18462940 doi:10.1016/j.bmcl.2008.04.043

Page seeded by OCA on Tue Feb 17 02:35:36 2009

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA

[1] Cogan DA, Aungst R, Breinlinger EC, Fadra T, Goldberg DR, Hao MH, Kroe R, Moss N, Pargellis C, Qian KC, Swinamer AD. Structure-based design and subsequent optimization of 2-tolyl-(1,2,3-triazol-1-yl-4-carboxamide) inhibitors of p38 MAP kinase. Bioorg Med Chem Lett. 2008 Jun 1;18(11):3251-5. Epub 2008 Apr 25. PMID:18462940 doi:10.1016/j.bmcl.2008.04.043

[xtra 1]

@@ Line 20: / Line 20: @@
 ==About this Structure==
-CTQ is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3CTQ OCA].
+CTQ is a 1 chain structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3CTQ OCA].
 ==Reference==
-Structure-based design and subsequent optimization of 2-tolyl-(1,2,3-triazol-1-yl-4-carboxamide) inhibitors of p38 MAP kinase., Cogan DA, Aungst R, Breinlinger EC, Fadra T, Goldberg DR, Hao MH, Kroe R, Moss N, Pargellis C, Qian KC, Swinamer AD, Bioorg Med Chem Lett. 2008 Apr 25;. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/18462940 18462940]
+<ref group="xtra">PMID:18462940</ref><references group="xtra"/>
 [[Category: Homo sapiens]]
 [[Category: Mitogen-activated protein kinase]]
-[[Category: Single protein]]
 [[Category: Qian, K.]]
 [[Category: Alternative splicing]]
@@ Line 42: / Line 41: @@
 [[Category: Two lobe kinase fold]]
-''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 06:17:21 2008''
+''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Feb 17 02:35:36 2009''